Epidemiology and etiology of premalignant and malignant urothelial changes

Scandinavian Journal of Urology and Nephrology, Supplement

Volumn 34, Issue 205, 2000, Pages 105-115

  Cohen, Samuel M ^a   Shirai, Tomoyuki ^b   Steineck, Gunnar ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder neoplasms; Epidemiology; Etiology; Urothelium

Indexed keywords

2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; AROMATIC AMIDE; BENZIDINE; PHENACETIN; PHOSPHORAMIDE MUSTARD;

BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; CELL TYPE; CIGARETTE SMOKING; CONFERENCE PAPER; DIET; DISEASE ASSOCIATION; HUMAN; MEAT; OCCUPATIONAL EXPOSURE; PRECANCER; PRIORITY JOURNAL; RISK FACTOR; SCHISTOSOMIASIS; SQUAMOUS CELL CARCINOMA; URETHRA; UROGENITAL TRACT TUMOR; ADENOCARCINOMA; BLADDER TUMOR; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; INCIDENCE; REVIEW; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; PRECANCEROUS CONDITIONS; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0034353139     PISSN: 03008886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Johansson SL, Cohen SM. Pathology of bladder cancer. In: Raghaven D, Scher M, Leibel SA, Lange PH, eds. Principles and practice of genitourinary oncology. Philadelphia, PA: Lippincott-Raven, 1997: 207-13.
2. Epstein JI, Amin MB, Reuter VR, Mostofi FK. Bladder consensus conference committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435-48.
3. Steineck G. Epidemiology and etiology. In: Droller MJ, ed. Bladder cancer: Current diagnosis and treatment. Totowa, NJ: Humana Press 2001 (in press).
4. Silverman DT, Rothman N, Devesa SS. Epidemiology of bladder cancer. In: Syrigos KN, Skinner DG, eds. Bladder cancer. Biology, diagnosis, and management. New York: Oxford University Press: 1999: 11-55.
5. Castegnaro M, Chernozemsky I. Endemic nephropathy and urinary tract tumors in the Balkans. Cancer Res 1987; 47: 3608-9.
6. Smith AH, Biggs ML, Moore L, Haque R, Steinmaus C, Chung J, et al. Cancer risks from arsenic in drinking water: implications for drinking water standards. In: Chappell WR, Abernathy CO, Calderon RL, eds. Arsenic exposure and health effects. Oxford, UK: Elsevier Science, 1999: 191-9.
7. Morrison AS, Proppe KH, Verhoek WG, Aoki K, Leck I, Ohno Y, et al. Histologic features of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. Int J Cancer 1982; 30: 701-5.
8. Stemmermann GN, Yoshizawa CN, Nomura AMY, Kolonel LN. Urothelial cancer in white and Japanese patients in Hawaii: Pathology. J Urol 1990; 144: 44-6.
9. Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D, et al Racial/ethnic patterns of cancer in the United States 1988-1992. Bethesda, MD: National Cancer Institute, NIH Publ. No. 96-4104, 1996.